In peptide therapy, GLP-1 analogs are used to mimic the effects of this hormone, leading to several weight loss benefits: Appetite Suppression: GLP-1 helps reduce hunger by signalling the brain to feel full
The global GLP-1 analogues market size was calculated at USD 66.48 billion in 2025 and is predicted to increase from USD 88.58 billion in 2026 to approximately USD 1,062.90 billion by 2035, expanding at a CAGR of 31.94% from 2026 to 2035
In the Prime Therapeutic study cited above, only one in four patients were still on Wegovy or Ozempic two years later
Backed by Science Momentous collaborates with leading scientists, leveraging cutting-edge research, patented ingredients, and direct clinical proof to develop best-in-class products
By clicking Accept, you agree to our use of cookies for the purposes listed in our Cookie Consent Tool.